ALLAKOS INC's ticker is ALLK and the CUSIP is 01671P100. A total of 166 filers reported holding ALLAKOS INC in Q3 2021. The put-call ratio across all filers is 0.51 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $250 | -91.5% | 110 | -83.7% | 0.00% | – |
| Q2 2023 | $2,934 | -60.6% | 673 | -59.7% | 0.00% | -100.0% |
| Q1 2023 | $7,440 | +85.3% | 1,672 | +250.5% | 0.00% | – |
| Q4 2022 | $4,016 | +100.8% | 477 | +38.7% | 0.00% | – |
| Q3 2022 | $2,000 | +100.0% | 344 | +134.0% | 0.00% | – |
| Q4 2021 | $1,000 | -93.3% | 147 | +7.3% | 0.00% | -100.0% |
| Q3 2021 | $15,000 | +25.0% | 137 | 0.0% | 0.00% | +33.3% |
| Q2 2021 | $12,000 | -29.4% | 137 | -4.9% | 0.00% | -25.0% |
| Q1 2021 | $17,000 | -10.5% | 144 | +5.1% | 0.00% | -20.0% |
| Q4 2020 | $19,000 | +72.7% | 137 | 0.0% | 0.01% | +66.7% |
| Q3 2020 | $11,000 | +10.0% | 137 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $10,000 | +150.0% | 137 | +42.7% | 0.00% | +50.0% |
| Q1 2020 | $4,000 | – | 96 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 270,965 | $12,055,000 | 6.94% |
| NEA Management Company, LLC | 2,268,188 | $100,912,000 | 5.27% |
| Fairmount Funds Management LLC | 178,662 | $7,949,000 | 4.82% |
| Redmile Group, LLC | 2,976,928 | $132,444,000 | 3.71% |
| Boxer Capital, LLC | 675,000 | $30,031,000 | 2.05% |
| Rock Springs Capital Management LP | 235,000 | $10,455,000 | 0.43% |
| Cormorant Asset Management, LP | 200,000 | $8,898,000 | 0.41% |
| RAMIUS ADVISORS LLC | 31,155 | $1,386,000 | 0.35% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 15,700 | $692,000 | 0.32% |
| Handelsinvest Investeringsforvaltning | 20,000 | $890,000 | 0.24% |